MAIN MENU

BACK

BACK

  • Home

  • About
  • News & Events
  • Careers
  • Countries
  • Contact Us
  • Volunteer
  • PAREXEL Academy
  • Partners
  • Client Login
Explore PAREXEL
  • JourneyGO
  • SolutionsGO
  • ExperienceGO
  • Outsourcing ModelsGO
  • Planning
  • Phase I
  • Phase IIa
  • Phase II-III
  • Phase IIIb-IV
  • Post Launch
  • Clinical Research
    • Early Phase Services
      • Dedicated Therapeutic Expertise
        • Early Phase and Late Phase integrated study management
      • Patient Populations
      • Strategic Locations
        • Berlin
          • Virtual Tour
        • London
          • Virtual Tour
        • Baltimore
          • Facility
          • Virtual Tour
        • Los Angeles
          • Virtual Tour
      • Phase 1, First in Human
        • Ethnobridging for Accelerated Global Drug Development
      • Phase IIa, Proof of Concept
      • Early Product Development
      • Ethnobridging
      • Clinical PK/PD and Pharmacometrics Services
        • Case Study: Safety/Pharmacovigilance #1
        • Case Study: Safety/Pharmacovigilance #2
      • Bioanalytical and Biomarkers
      • Bioequivalence Studies
      • Volunteer to Participate
    • Phase II-III Services
      • Phase III
        • Case Study: Chronic Renal Failure
        • Case Study: Expanded Access Program
        • Case Study: Accelerating development in global COPD trials
      • Medical Writing and Submission
      • Feasibility and Enrollment
        • Patient Recruitment
          • Case Study: Pediatric Migraine Patient Recruitment
        • Country and Site Selection
        • Alliance Site Strategy
        • Protocol Optimization
    • Phase IIIb-IV
    • ForeSite™ Clinical Trial Methodology
      • Study Design
      • Study Start-Up
      • Study Execution
    • Global Data Operations
      • Clinical Data Management
      • Biostatistics Services
      • Clinical MetaData Repository (MDR)
    • Medical Writing Solutions
    • Quantitative Clinical Development Services
    • Clinical Trial Supplies & Logistics
      • Global Reach
      • Clinical Trial Supplies
      • Ancillary Supplies
      • Laboratory Logistics and Biological Sample Lifecycle Management Services
      • Randomization and Trial Supply Management
      • Cold Chain Logistics
      • Clinical Trial Supply Chain - Active Tracking
    • Customer Care Services
    • Genomic Medicine Services
    • Clinical Adjudication Services
  • Informatics
    • Regulatory and Clinical Technology
      • Regulatory Information Management
        • LIQUENT InSight®
        • Regulatory Cloud
        • Regulatory Outsourcing Services
      • Data-Driven Monitoring
      • Clinical Trial Management System (CTMS)
        • IMPACT® CTMS Software
      • Electronic Data Capture
        • DataLabs® EDC
      • MyTrials® Analytics
    • Patient Technology
      • Randomization and Trial Supply Management
        • Clinical Trial Supplies & Logistics
        • Clinical Trial Supply Chain - Active Tracking
        • ClinPhone RTSM Mobile App
      • Medical Imaging
        • Therapeutic Expertise
          • Oncology Imaging Expertise
            • Criteria Experience
              • 1996 NCI-WG CLL
              • IWCLL 2008
                • Key Topics: IWCLL 2008
                  • Definitions
                  • Usable Criteria to Evaluate
                  • Target Sites of Disease
                  • Non-Target Sites of Disease
                  • Organomegaly
                  • New Lesions
                  • B symptoms
                  • Blood Counts
                  • Bone Marrow
                  • Transformation
                  • Role of Imaging in CLL Clinical Trials
                  • Clinical Data Assessments
              • 1999 IWG-NHL
              • 2007 IWG-NHL
                • Key Topics: 2007 IWG-NHL Assessment Criteria
                  • Definitions
                  • Usable Criteria to Evaluate
                  • Target Sites of Disease
                  • Non-Target Sites of Disease
                  • Organomegaly
                  • New Lesions
                  • Bone Marrow
                  • Other Laboratory Values and Symptoms
                  • Incorporation of FDG-PET
                  • Defining Normal, Abnormal and Measurable
                  • Problem with CRu
              • RECIST
          • Neurology Imaging Expertise
          • Musculoskeletal (MSK) Imaging Expertise
          • Women's Health Imaging Expertise
          • Dermatology Imaging Expertise
          • Gastroenterology Imaging Expertise
          • Ophthalmology Imaging Expertise
          • Volumetric Imaging Expertise
          • Cardiovascular Imaging Expertise
        • Imaging Services
        • Scientific Advisors
        • Consultation
        • Advanced Medical Imaging
          • Cloud-Based Solutions for Sites
      • Patient Sensors
      • Electronic Clinical Outcome Assessments (eCOA)
        • ePRO (electronic Patient Reported Outcomes)
        • Clinical Outcome Assessments Consulting
    • Clinical Trial Supplies & Logistics
    • Perceptive® Cloud
    • Asset Transfer Services
    • PAREXEL's Education Services
      • IMPACT® CTMS Training
      • LIQUENT InSight® Training
        • Courses & Registration
          • LIQUENT InSight® for Submission Management
            • LIQUENT InSight®Submission Planning and Tracking
          • LIQUENT SmartDesk™
            • Automating the Publishing Process with LIQUENT SmartDesk™ for PDF
          • LIQUENT InSight for Viewing
            • Reviewing Submissions with LIQUENT InSight® for Viewing
        • Training Resources
      • DataLabs® EDC Training
      • Perceptive MyTrials® Training
      • Data-Driven Monitoring Training
      • Certification Programs
      • Other Training Services
    • Customer Care Services
  • Consulting
    • Integrated Product Development
      • A Biosimilar Milestone with Implications
    • Regulatory Compliance & Risk Management
      • Q&A about GCP
        • Quality By Design Putting Theory Into Practice
      • Strategic Compliance: Data Integrity
      • FDA 483s: Your Questions Answered
      • Important Reminder About PET (Positron Emitting Topography) FDA Regulations
      • Quality By Design Putting Theory Into Practice
    • Regulatory Outsourcing Services
      • eCTD
    • Regulatory Information Management & IDMP Solutions
      • IDMP Readiness Assessment
      • IDMP Task Force Updates
        • November 2015 Task Force Meeting
    • Market Access Consulting
  • Access
    • Real World Evidence
      • Late Phase Clinical Operations
        • Late Phase Interventional Trials
        • Observational Research
        • Epidemiology
        • Expanded Access Programs
        • Clinical Outcome Assessment (COA)
          • Case Study: Health Economics
          • Outcomes Research
      • Real World Data Services
    • Drug Safety Services
      • Risk Management / REMS
    • Market Access Consulting
      • Commercial Decision Pathways
      • Evidence Generation
        • Evidence Review and Meta-Analysis
          • Evidence Review Options
          • Evidence Review Resources
        • Health Economic Modeling
        • Global and AMCP Value Dossiers
        • Manuscripts and Posters
        • Data Analytics
        • Strategic Communications
      • Access Realization
        • Pricing, Reimbursement and Market Access Expertise
        • List of Services: Pricing, Reimbursement and Market Access
    • Medical Communications
      • Communication Strategy
      • Publications Planning and Scientific Content
      • Expert Identification and Engagement
      • Global Study Engagement
      • Branding and Creative Strategy
      • Digital Media and Video Solutions
      • Live and Virtual Events
      • Payer Communication
      • Editorial and Production
    • Outsourced Field-Based Medical Teams
  • Therapeutic Expertise
    • Oncology
    • Cardiovascular & Metabolic Diseases
    • Central Nervous System (CNS) Disorders
    • Infectious Disease
    • Respiratory Capabilities
    • Rheumatology & Immunology Capabilities
    • Rare Diseases
  • Industry Expertise
    • Pharmaceuticals
      • Biosimilar Consulting
    • Medical Devices
    • Biologics
    • Biosimilars
      • Biosimilar Video
  • Regulatory Expertise
  • Market Access Expertise
  • Global Presence
    • North America
    • South America
    • Europe
    • Asia
    • Middle East & Africa
    • Emerging Markets
  • Strategic Partnerships
  • ExecuPharm Functional Service Solutions
  • PAREXEL® BioPharm Unit
  • About
  • News & Events
  • Careers
  • Countries
  • Contact Us
  • Volunteer
  • PAREXEL Academy
  • Partners
  • Client Login
  • Journey
    • Planning
    • Phase I
    • Phase IIa
    • Phase II-III
    • Phase IIIb-IV
    • Post Launch
  • Solutions
    • Clinical Research
      • Early Phase Services
      • Phase II-III Services
      • Phase IIIb-IV
      • ForeSite™ Clinical Trial Methodology
      • Global Data Operations
      • Medical Writing Solutions
      • Quantitative Clinical Development Services
      • Clinical Trial Supplies & Logistics
      • Customer Care Services
      • Genomic Medicine Services
      • Clinical Adjudication Services
    • Informatics
      • Regulatory and Clinical Technology
      • Patient Technology
      • Clinical Trial Supplies & Logistics
      • Perceptive® Cloud
      • Asset Transfer Services
      • PAREXEL's Education Services
      • Customer Care Services
    • Consulting
      • Integrated Product Development
      • Regulatory Compliance & Risk Management
      • Regulatory Outsourcing Services
      • Regulatory Information Management & IDMP Solutions
      • Market Access Consulting
    • Access
      • Real World Evidence
      • Drug Safety Services
      • Market Access Consulting
      • Medical Communications
      • Outsourced Field-Based Medical Teams
  • Experience
    • Therapeutic Expertise
      • Oncology
      • Cardiovascular & Metabolic Diseases
      • Central Nervous System (CNS) Disorders
      • Infectious Disease
      • Respiratory Capabilities
      • Rheumatology & Immunology Capabilities
      • Rare Diseases
    • Industry Expertise
      • Pharmaceuticals
      • Medical Devices
      • Biologics
      • Biosimilars
    • Regulatory Expertise
    • Market Access Expertise
    • Global Presence
      • North America
      • South America
      • Europe
      • Asia
      • Middle East & Africa
      • Emerging Markets
  • Outsourcing Models
    • Strategic Partnerships
    • ExecuPharm Functional Service Solutions
    • PAREXEL® BioPharm Unit
  • Company
    • Management Team
      • Jamie Macdonald
      • Roland Andersson, Ph.D.
      • Michael Crowley
      • Xavier Flinois
      • Michele Fournier
      • David J. Godwin
      • Simon Harford
      • Sy Pretorius, M.D.
      • Gadi Saarony
    • News & Events
      • Press Releases
      • Events
      • Webinars
      • 12th Annual Partnerships in Clinical Trials Congress
      • Archived PAREXEL in the News
    • Find an Office
    • Careers
      • Careers at PAREXEL®
      • CEO Message
      • Find Your Path - Opportunities
      • University Graduates – Opportunities for students
    • Volunteer
      • About Us
      • Locations Worldwide
      • About Clinical Trials
      • Why Participate?
      • FAQs
      • Glossary
    • Sustainability
      • Consumption Trend Analysis
    • Code of Conduct
    • eClinical Innovation
    • Purchasing
      • Purchase Order Terms and Conditions
      • Bedingungen für den Kaufauftrag
      • Vigente desde el
      • PO Terms - Japanese
      • PO Terms - Chinese 'S'
      • PO Terms - Chinese 'T'
      • Ordem de Compra Termos e Condições
    • Contact Us
      • Thank You
    • Partners
      • Service Partners
      • Training Partners
      • Technology Partners
      • Referral Partners
      • Accredited Partner Program
    • PAREXEL Reports U.K. Gender Pay Data
  • Perceptive®
  • User Group Meeting
    • IMPACT CTMS User Group Meeting Details and Agendas
    • IMPACT CTMS User Group Meeting Justification Letter
    • Meeting Registration and Hotel Details
    • Benefits for attending the IMPACT CTMS User Group Meeting
    • Registration Rates
    • Hotel Rates
  • Horizons
    • About
    • Locations
    • FAQs
    • Agenda
  • RWE Symposia
    • About
    • Locations
    • FAQs
    • Agenda
  • Graduate | PAREXEL
    • Culture at PAREXEL
    • Former Trainees at PAREXEL
      • Career Trainee Meghan
      • Career Trainee Sam
    • Great Place to Work
    • PAREXEL Overview
    • Clinical Trainee Program Belgium
    • Clinical Trainee Program Japan
    • Graduate Scheme India
    • Clinical Research Awards
    • Graduate Scheme UK
  • parexel-insights
    • When It Comes to CTMS One Size Does Not Fit All
    • This Disease Will Not Win the Fight
    • Designing Trials Payers Can Trust
    • Utilizing Secondary Healthcare Data Assets
    • RIM & IDMP Synergies
    • Clarifying the Criteria that Better Capture Antitumor Activity of Immune Therapeutics
    • 'Now is the time to include Japan' says PAREXEL
    • High Performance Workplace Practices That Attract and Retain Millennials
    • Clinical Trial Feasibility & Patient Enrollment: Differentiation Through Innovation
    • Developing Drugs in the New Era of Personalized Medicines
    • Interview with PAREXEL’s Aida Sabo, About Challenges & Successes in Diversity & Inclusion
    • Imaging Endpoint Selection For Biosimilar Development
    • CONSIDERATIONS IN BIOSIMILARS DEVELOPMENT– A US FDA PERSPECTIVE
    • Protocol Optimization
    • New Approaches to Data Management in Clinical Trials
    • 30 Years Later: Lessons from Living in a Pandemic
    • Why RTSM & IRT stand for Speed, Simplicity & Service
    • PAREXEL’s Training Approach and the Importance of Training a Global Workforce
    • Involved & Engaged: The Last Mile of Business Performance
    • Adaptive Trials: Complex But Advantageous
    • Grateful for Advancements in Medicine
    • The Human Touch: Aligning Reward Systems with Company Strategy and Meaningful Work
    • Orphan Drug Pricing in Europe
    • Generating Evidence to Drive Patient Access
    • Life is Short and Love is Eternal
    • The Complete Journey: Improving Clinical Trials Using Modern Technology
    • A People Strategy Attracts the Best Talent
    • Clinical Development of Next Generation Biologics
    • Best Practices to Improve the IRT Site User Experience
    • If You Never Stop Learning, You Can Never Stop Earning
    • PAREXEL's Connected Journey™ of Data-Driven Services
    • Focused on the Finish Line
    • Using Analytics to Optimize The Clinical Development Process
    • Accelerated Pathways: Global Opportunities & Challenges for Innovators
    • Immuno-Oncology: Past, Present and Future
    • How do eClincal solutions Increase Clinical Trial Efficiency?
    • Successfully Integrating Electronic Health Record and Electronic Data Collection Data
    • How to Maximize Potential and Sidestep Pitfalls of MAPs
    • World Cancer Day: Reflecting on Progress and Hope for Patients
    • Progress in Pursuit of a Cure - World AIDS Day 2017
    • How Performance Reviews Support High-Performance Talent
    • How Protocol Optimization Improves Clinical Trial Outcomes
    • Optimizing the clinical development process with Social, Mobile, Analytics, and Cloud (SMAC)
    • Overcoming Data Capture and Management Challenges
    • Running with a Purpose
    • Three Keys To Mitigating Risk In Adaptive Trials
    • Diversity and Inclusion: This Is How the Best Global Companies Learn, Plan, and Measure Success
    • Key Considerations In Biologics Clinical Development
    • Data Management Roles, Process and Technologies in Risk Based Study Execution
    • Recorded Webinar: Getting to Approval Faster Through Technology Innovation
    • Attitude is Everything
    • Innovation in the Pharmaceutical Industry: A Change Toward Personalized Medicine
    • Dr. Sy Pretorius, Chief Scientific Officer Talks About Adaptive Design Trials
    • Dream or Reality- Improving Patient Safety & Reducing Costs?
    • Your clinical trial supply may be at risk – Brexit and the impact on IMP distribution
    • You’re Hot Then You’re Cold -Temperature Management & RTSM Integration
    • Precision Medicine’s Next Hurdle: Quality Management of Human Samples
    • Genomic Medicine, Data Modeling and Clinical Trials
    • Dragons - the Guardians of Disease
    • Recognizing Uncle David
    • Shogo Nakamori Discusses Joint Program for Clinical Research
    • Increasing Study Predictability
    • Demonstrating Value and Managing Risk Throughout Development
    • Shogo Nakamori Discusses Trends in Drug Development in Japan
    • Navigating Regulatory Submissions
    • Get Into Pole Position with Modern IRT Services
    • Quantitative Modeling For Clinical Trials
    • PAREXEL Celebrates International Women's Day 2018
    • On Demand Webinar - The Power of Foresight: Improving Drug Development Performance through Optimized Protocol Design
    • Drew Garty Discusses Data Driven Monitoring
    • Beyond Diversity: What Happens When You Define a Culture of Inclusion
    • Want Your Business to Thrive? Focus on Developing Your People
    • Rooting for Team Jessie
    • Anything is Possible
    • Contracting - A Key Component Of A Strong Vendor Relationship
    • The Next Generation of Talent Management: Opportunities For Diversity
    • Albert Siu, PhD, Explains How PAREXEL Academy Benefits Clients
    • How to Know You’re Keeping Your (Clinical Trial Supplies) Cool
    • What You Need To Know About Biosimilars Development
    • Improving Site Experience with Risk-Based Monitoring
    • Aligning on Patient Outcomes – How Market Dynamics Can Facilitate RWD (Real World Data) Solutions in Research
    • Shogo Nakamori Discusses Japan & Multi-national Trials
    • Roland Andersson, SVP, Discusses Investing Trends and Emerging Biopharmaceutical Companies
    • Accelerated Pathways and Stock Prices
    • Three Skills Developers Will Need to Thrive in the New Era of Genomic Medicine
    • Navigating Regulatory Complexities Of Biosimilar Development
    • Wearables Shaping the Future of Clinical Trials
    • Josh Schultz, Corp. VP Talks About PAREXEL Access
    • The Collaborative Advantage of Biopharma Companies and Global Service Providers
    • Mergers & Acquisitions: Where’s the Real Finish Line?
    • 3 Principles for a Sound Clinical and Regulatory Document Strategy for Small Biopharmaceuticals
    • Why Strategy is Not Enough: Building the Bridge From Strategy to Results Requires Organizational Excellence
    • Training Compliance is an Increasingly Complex Journey
    • Something Good Always Comes From Something Bad
    • Leveraging the Cloud to Accelerate Time to Treatment
    • Working Towards a Glimpse of a Cure
    • Clinical Trial Support Query - Who Ya Gonna Call?
    • World Cancer Day: Breakthroughs and Challenges for Precision Medicine
    • Surveillance or Surgery?
    • "Yes, I Can!"
    • A Biosimilar Milestone with Implications
    • Accelerated Pathways & Commercial Consequences Forum & Findings
    • The Clinical, Regulatory and Commercial Implications of Rapid Approval
    • Medical Writing for Submission to Asia-Pacific Regulatory Authorities
    • How to Simplify Site Tasks and Help Ensure Dispensing Accuracy
    • WHAT CAN WE LEARN FROM IMMUNO-ONCOLOGY CLINICAL TRIALS?
    • Albert Liou Discusses the Drug Development Landscape in Korea
    • Effective Late Stage Pathways For Biosimilar Products
    • Biosimilar mAbs – a unique and distinct market (for the time being…?)
    • When the Doctor Becomes the Patient
    • The Life of a Human Biological Sample: A Look Inside and How to Maintain Its Integrity
    • The Impact of the Digital Human Resources Organization on People - Part 1
    • The Evolution of Drug Development & Market Access via Connected Data-driven Solutions
    • The Emerging Role of Wearable Devices For Real-World Data Collection
    • Active Tracking Is Out To Reduce Sites’ Workload
    • Ubavka DeNoble Talks About PAREXEL's BioPharm Unit
    • The Journey Continues – I Got This
    • So, My Fitbit is Clinical Trial Grade Right?
    • Latin America’s Role in Clinical Studies
    • Trends in Translational Development
    • Effective use of Value to Achieve Optimal Market Access
    • Three Ways to Mitigate the Risk of Late-stage Failure in CNS Drug Development
    • HOW TO EFFECTIVELY DEVELOP CLINICAL DOCUMENTS IN THE EU/US AND CHINA NDA DOSSIER
    • The Art and Science of Productive FDA Meetings
    • Driving the Digital Transformation of the Industry
    • Regulatory Strategy In Emerging Markets
    • Exploring Our Partnership with CHA Medical Group
    • PAREXEL Introduces Jamie Macdonald as Chief Executive Officer
    • Understanding different stakeholder requirements throughout commercialization
    • Development considerations: Comparing major markets including US, EU, Japan and China
    • Risk and Common Mistakes in Import and Export Documentation for Clinical Trials
    • Operational Aspects Of Independent Reviews for Immune-Oncology Clinical Endpoints
    • PAREXEL Academy Introduces New Collaboration to Develop Japan’s Biopharmaceutical Workforce of the Future
  • agile-IRT
    • Agile IRT
    • Reduced Timelines
    • Simpler Processes
    • Expert Services
    • Contact
  • test
    • Graduate | PAREXEL
  • Menu
Home > Solutions > Informatics > Patient Technology > Electronic Clinical Outcome Assessments (eCOA) > Clinical Outcome Assessments C...

Clinical Outcome Assessment Consulting

PAREXEL® provides expert scientific and operational services to optimize the design and implementation of studies that include the collection of COA data. These services include the selection of the most relevant instrument(s) for studies, their refinement and application in a new setting if required, as well as new instrument development. Study implementation planning expertise is then available to optimise data quality and operational expertise is applied to data collection, analysis, interpretation and reporting of studies.  Our project management and procurement expertise also enables us to effectively manage the contribution of niche services and technology providers as required. Our expert capabilities include:

Development, modification and validation of instruments
PAREXEL’s core questionnaire development activities are patient diaries and surveys to capture patient reported data in late phase studies. PAREXEL has successfully designed and implemented hundreds of questionnaires in many different languages.  PAREXEL can also create, modify and perform validation of instruments to meet stringent regulatory requirements including cognitive debriefing, user acceptance testing as well as equivalence testing or full psychometric validation.

PAREXEL can perform clinical studies to pilot newly created or modified instruments in a target population, facilitated by access to investigators in most major markets, who assist by providing country and culture-specific guidance, as well as in-country data collection.

Conducting qualitative and quantitative research  
PAREXEL offers high-level market research expertise and implementation capabilities. We are able to identify specific patient populations and conduct interviews in the local language as well as convening and facilitating patient focus groups. Individuals are identified using a number of different access routes including via treating physicians. Our approach combines a commitment to understanding context, using effective research methods, and providing insightful results. In addition, PAREXEL can quantitatively advise on the relative financial impact of selecting specific instruments and advising on those with the greatest likelihood of achieving a positive financial outcome.

Translation and linguistic validation
PAREXEL works with a small number of established and highly respected industry leaders who can provide global specialist PRO translation and validation services. These specialist providers are integrated and managed as part of the PAREXEL study project team.

White Paper ePRO for Global Clinical Trials

Learn more about ePRO for Global Trials and best practices for ePRO collaboration.

White Paper Testing Interactive Voice Response (IVR) and Paper Versions of the Eq-5d

Learn more about testing Interactive Voice Response (IVR) and Paper Versions of the Eq-5d.

White Paper The Value of Computer-admistrated Self-reported Data

Learn more about the Value of Computer-administrated Self-reported Data in central nervous system clinical trials.

Make part of your solution

PAREXEL provides expert scientific and operational services to optimize the design and implementation of studies that include the collection of COA (Clinical Outcome Assessment) data.

Electronic Clinical Outcome Assessments (eCOA)

Products and Services

Clinical Outcome Assessments (COAs) measure a patient’s symptoms, overall mental state, or the effects of a disease or condition on how the patient functions. COAs can be used to determine whether or not a drug has been demonstrated to provide treatment benefit. COA types include ePRO (electronic Patient Reported Outcomes).

  • ePRO (electronic Patient Reported Outcomes)
  • Clinical Outcome Assessments Consulting

    The Power of ePRO

    curved_glass_hall_165_x_165_.png

    In the past few years, drug developers and regulatory agencies have become increasingly receptive to the use of electronic patient-reported outcomes (ePRO) devices in clinical trials.

    learn more

    Customer Care

    customer_care_165_x_165_.png

    Expertise for every phase of your journey.

    learn more

    Linkedin Updates

    View Profile
    • Congratulations to our colleague, Sue Metz, on her appointment as CEO of IRISS - a collaborative non-profit organi... Read More
    • Visit PAREXEL at Booth 13 during @ISMPP (Apr. 30-May 2) to discuss emerging medical communications trends with our ... Read More
    • PAREXEL's Bob Desai will discuss Orphan Drug designations in an era of novel technologies on Apr. 27 during the Wor... Read More

    CAREERS AT PAREXEL®

    If you are inspired to make a difference
    in the world, we can help you make it possible.

    Search job openings worldwide

    PAREXEL International Corp.
    +1 781 487 9900
    195 West Street
    Waltham, MA 02451 

    • ABOUT PAREXEL®
    • NEWS & EVENTS
    • VOLUNTEER
    • CONTACT
    • MY PAREXEL PREFERENCE CENTER
    • CLIENT LOGIN
    • LIQUENT®
    • CLINICAL TRIAL INVESTIGATOR
    • SITE MAP
    • TERMS OF SERVICE
    • PRIVACY POLICY
    • EU-U.S. AND SWISS-U.S. PRIVACY SHIELD NOTICE OF CERTIFICATION

    Copyright ©2000-2018 PAREXEL International Corporation.